Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Dec 2016)

Polymorphisms in the GNAS Gene as Predictors of Ventricular Tachyarrhythmias and Sudden Cardiac Death: Results From the DISCOVERY Trial and Oregon Sudden Unexpected Death Study

  • Heinrich Wieneke,
  • Jesper Hastrup Svendsen,
  • Jeffrey Lande,
  • Sebastian Spencker,
  • Juan Gabriel Martinez,
  • Bernhard Strohmer,
  • Lauri Toivonen,
  • Hervé Le Marec,
  • F. Javier Garcia‐Fernandez,
  • Domenico Corrado,
  • Adriana Huertas‐Vazquez,
  • Audrey Uy‐Evanado,
  • Carmen Rusinaru,
  • Kyndaron Reinier,
  • Csaba Foldesi,
  • Wieslaw Hulak,
  • Sumeet S. Chugh,
  • Winfried Siffert

DOI
https://doi.org/10.1161/JAHA.116.003905
Journal volume & issue
Vol. 5, no. 12

Abstract

Read online

BackgroundPopulation‐based studies suggest that genetic factors contribute to sudden cardiac death (SCD). Methods and ResultsIn the first part of the present study (Diagnostic Data Influence on Disease Management and Relation of Genetic Polymorphisms to Ventricular Tachy‐arrhythmia in ICD Patients [DISCOVERY] trial) Cox regression was done to determine if 7 single‐nucleotide polymorphisms (SNPs) in 3 genes coding G‐protein subunits (GNB3, GNAQ, GNAS) were associated with ventricular tachyarrhythmia (VT) in 1145 patients receiving an implantable cardioverter‐defibrillator (ICD). In the second part of the study, SNPs significantly associated with VT were further investigated in 1335 subjects from the Oregon SUDS, a community‐based study analyzing causes of SCD. In the DISCOVERY trial, genotypes of 2 SNPs in the GNAS gene were nominally significant in the prospective screening and significantly associated with VT when viewed as recessive traits in post hoc analyses (TT vs CC/CT in c.393C>T: HR 1.42 [CI 1.11‐1.80], P=0.005; TT vs CC/CT in c.2273C>T: HR 1.57 [CI 1.18‐2.09], P=0.002). TT genotype in either SNP was associated with a HR of 1.58 (CI 1.26‐1.99) (P=0.0001). In the Oregon SUDS cohort significant evidence for association with SCD was observed for GNAS c.393C>T under the additive (P=0.039, OR=1.21 [CI 1.05‐1.45]) and recessive (P=0.01, OR=1.52 [CI 1.10‐2.13]) genetic models. ConclusionsGNAS harbors 2 SNPs that were associated with an increased risk for VT in ICD patients, of which 1 was successfully replicated in a community‐based population of SCD cases. To the best of our knowledge, this is the first example of a gene variant identified by ICD VT monitoring as a surrogate parameter for SCD and also confirmed in the general population. Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT00478933.

Keywords